ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681641 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681641; 2) Community: the network communities that were significantly associated with the response to NSC 681641; 3) Molecule: the relationships between components within communities and NSC 681641; 4) MDR: the compounds that were significantly associated with the NSC 681641.

NSC Compound Enrichment Correlation
NSC 19441 FDA 0283 0.00116011782209856 0.41523431
NSC 48006 WLN: T6N CNJ DZ EF F- BT5OTJ EO1 0.00116011782209856 0.42585872
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0016365323975257 0.04223097
NSC 681634 Camptothecin Derivative 0.00163653239752571 0.84792534
NSC 681644 Camptothecin Derivative 0.00163653239752573 0.8624268
NSC 706744 Indenoisoquinoline derivative 0.00163653239752573 0.71064071
NSC 740362 Null 0.00163653239752573 0.11617614
NSC 694698 Null 0.00211131723826695 0.022364572
NSC 176323 Camptothecin Derivative 0.00211131723826697 0.82605001
NSC 295499 Camptothecin Derivative 0.00211131723826697 0.81409155
Total:60  Current:4    [First] [Prev] [Next] [Last]